- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Angiotensin in ECMO patients with refractory shock ; volume:22 ; number:1 ; day:1 ; month:11 ; year:2018 ; pages:1-3 ; date:12.2018
Critical care ; 22, Heft 1 (1.11.2018), 1-3, 12.2018
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-018-2225-4
- URN
-
urn:nbn:de:101:1-2018122019080659514598
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ostermann, Marlies
- Boldt, David W.
- Harper, Michael D.
- Lim, George W.
- Gunnerson, Kyle
- SpringerLink (Online service)
Ähnliche Objekte (12)
Postcardiotomy VA-ECMO for refractory cardiogenic shock
Angiotensin II: a new approach for refractory shock management?
Angiotensin II in ECMO patients: a word of caution
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
ECMO in cardiac arrest and cardiogenic shock
Should ECMO be used in cardiogenic shock?
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
Do we need another prognostic score for cardiogenic shock patients with ECMO?
Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients
Postcardiotomy VA-ECMO for refractory cardiogenic shock
Angiotensin II: a new approach for refractory shock management?
Angiotensin II in ECMO patients: a word of caution
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
ECMO in cardiac arrest and cardiogenic shock
Should ECMO be used in cardiogenic shock?
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
Do we need another prognostic score for cardiogenic shock patients with ECMO?
Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients
Postcardiotomy VA-ECMO for refractory cardiogenic shock
Angiotensin II: a new approach for refractory shock management?
Angiotensin II in ECMO patients: a word of caution
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
ECMO in cardiac arrest and cardiogenic shock
Should ECMO be used in cardiogenic shock?
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
Do we need another prognostic score for cardiogenic shock patients with ECMO?
Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis